Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - JUNIPER PHARMACEUTICALS INC | jnp-ex312_6.htm |
10-K/A - 10-K/A - JUNIPER PHARMACEUTICALS INC | jnp-10ka_20171231.htm |
Exhibit 31.1
Certification Pursuant to Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934
I, Alicia Secor, certify that:
1. I have reviewed this Amendment to the Annual Report on Form 10-K/A of Juniper Pharmaceuticals, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
/s/ Alicia Secor |
Alicia Secor |
President and Chief Executive Officer (Principal Executive Officer) |
DATE: April 27, 2018 |